Category: Series
-
![To Invest or Not: TGS Esports (TGS.V) on a Mission to Dominate the Industry! Should Investors Step-In?]()
To Invest or Not: TGS Esports (TGS.V) on a Mission to Dominate the Industry! Should Investors Step-In?
In this episode, we take a look at TGS Esports with its first-of-its-kind Esports Stadium in Canada and end-to-end platform. The Richmond-based company managed to bring in revenue of up to $1 billion in 2020 and continue to work with big names like Red Bull, HyperX and Ubisoft. What could also this mean for potential…
-
![TGS Esports (TGS.V) reports record monthly revenue, stock still sluggish.]()
TGS Esports (TGS.V) reports record monthly revenue, stock still sluggish.
Stock Performance TGS Esports (TGS.C) ordinary common stock has had a rough ride over the last year. On Aug 18, 2020, the stock was trading at $0.13 and over a 77-day period ending November 2, 2020, the stock lost 22% of its value closing at $0.10. Following the 22% drop was a chain of amazing…
-
![NuRan Wireless (NUR.C) telecommunications mission could close the digital divide in Africa]()
NuRan Wireless (NUR.C) telecommunications mission could close the digital divide in Africa
Time for some real talk about Africa. Doing business there is neither easy nor for the faint of heart. It’s a continent with a history of rich countries profiting from its pain, and it’s short on success stories where everyone wins and nobody loses. This could change all that. The digital divide is the gap…
-
![Nuran Wireless (NUR.C) : Has the potential for $44 million in annual sales]()
Nuran Wireless (NUR.C) : Has the potential for $44 million in annual sales
Stock Performance It’s common to see a stock chart like the one below when some very big news has hit the market and investors are pricing in this new material information. Sometimes this could be the firm signaling to the market developments or basically setting in stones strategic goals and testing to see if the…
-
![Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor]()
Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor
Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8 million in cash and cash equivalents. This includes $5 million which was raised through a private placement that closed on June 21. That private placement included…
-
Filament Health (FH.NE) takes a natural approach to the $16 billion USD anxiety & depression market
Filament Health (FH.NE) is developing a pipeline of natural psychedelics products to treat mental health problems like depression and anxiety. August 3, 2021, FH received a patent for the technology used to transform psychedelic raw materials, like psilocybin-bearing mushroom, into pharma-grade extracts. “This approval represents important progress in the development of our IP,” stated Benjamin…
-
![Filament Health (FH.NEO) Leading the way in Natural Psychedelics. But Is it a Good Long Term Investment?]()
Filament Health (FH.NEO) Leading the way in Natural Psychedelics. But Is it a Good Long Term Investment?
In this episode, we take a look at a company that’s on a mission to get safe, natural psychedelics into the hands of everyone who needs them, as soon as possible. Filament Health (FH.NEO) is an exclusively natural psychedelic drug development company and received the first-ever psilocybin extraction and standardization patent for a public company…
-
![Filament Health (FH.NE): the natural psychedelic company flying under the radar]()
Filament Health (FH.NE): the natural psychedelic company flying under the radar
For the vast majority of the history of human use of psychedelics, they have been seen as something sacred, a gift from God or mother nature herself. Ayahuasca, which contains DMT, was given out by shamans in the Amazon as a tea. It was a spiritual experience that would purge you of your negative energy…
-
![Perimeter (PINK.V) has developed A.I. that radically improves breast cancer surgery outcomes]()
Perimeter (PINK.V) has developed A.I. that radically improves breast cancer surgery outcomes
There is a tendency in our culture to avoid talking about illness. It’s a downer. It’s bad voodoo. Why rattle the cage? But when people do decide to speak bluntly about illness, the reaction is usually positive. “Breast cancer in women has leap-frogged lung cancer, now accounting for the most cancer diagnoses worldwide – and…
-
![Perimeter Medical Imaging (PINK.V) CEO Jeremy Sobotta on Better Breast Cancer Surgery]()
Perimeter Medical Imaging (PINK.V) CEO Jeremy Sobotta on Better Breast Cancer Surgery
Jody Vance, well-known Vancouver-based talk show personality talks with Jeremy Sobotta, Perimeter Medical Imaging (PINK.C) CEO, to get a good look at the company’s mandate of improving the effectiveness of breast cancer surgery by getting everything the first time and how that will impact cancer treatment. We take a look at the technology, the company,…
